Online citations, reference lists, and bibliographies.
← Back to Search

Differential T Cell Costimulatory Requirements In CD28-deficient Mice.

A. Shahinian, K. Pfeffer, K. Lee, T. Kündig, K. Kishihara, A. Wakeham, K. Kawai, P. Ohashi, C. Thompson, T. Mak
Published 1993 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
T cell receptor stimulation without costimulation is insufficient for the induction of an optimal immune response. It is thought that engagement of the CD28 molecule with its ligand B7 provides an essential costimulatory signal without which full activation of T cells cannot occur. A mouse strain with a defective CD28 gene was established. Development of T and B cells in the CD28-deficient mice appeared normal. However, T lymphocytes derived from CD28-/- mutant mice had impaired responses to lectins. Lectin stimulation did not trigger interleukin-2 (IL-2) production, IL-2 receptor alpha expression was significantly decreased, and exogenous IL-2 only partially rescued the CD28 defect. Basal immunoglobulin (Ig) concentrations in CD28-deficient mice were about one-fifth of those found in wild-type controls, with low titers of IgG1 and IgG2b but an increase in IgG2a. In addition, activity of T helper cells in CD28-/- mice was reduced and immunoglobulin class switching was diminished after infection with vesicular stomatitis virus. However, cytotoxic T cells could still be induced and the mice showed delayed-type hypersensitivity after infection with lymphocytic choriomeningitis virus. Thus, CD28 is not required for all T cell responses in vivo, suggesting that alternative costimulatory pathways may exist.
This paper references
Requirement for an Ia-bearing accessory cell in Con A-induced T cell proliferation.
G. Ahmann (1978)
10.1016/S0070-2153(08)60675-4
Embryo-derived stem cells: a tool for elucidating the developmental genetics of the mouse.
A. Bradley (1986)
10.1038/328267A0
A new member of the immunoglobulin superfamily—CTLA-4
J. Brunet (1987)
10.1016/0092-8674(87)90646-5
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
K. Thomas (1987)
Functional analysis of T lymphocyte subsets in antiviral host defense.
T. Leist (1987)
10.1038/332040A0
T-cell receptor Vβ use predicts reactivity and tolerance to Mlsa- encoded antigens
H. Macdonald (1988)
10.1002/EJI.1830180404
An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus
Hanspeter Roost (1988)
10.1073/PNAS.86.4.1333
CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.
C. Thompson (1989)
10.1101/SQB.1989.054.01.003
Approaching the asymptote? Evolution and revolution in immunology.
C. Janeway (1989)
10.1016/0092-8674(89)90044-5
Acquisition of immunologic self-tolerance
R. Schwartz (1989)
10.1016/0092-8674(89)90905-7
Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells
S. Thompson (1989)
10.1126/SCIENCE.2540528
Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway.
T. Lindstein (1989)
The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression.
J. Gross (1990)
The genomic organization of the CD28 gene. Implications for the regulation of CD28 mRNA expression and heterogeneity.
K. Lee (1990)
10.1073/PNAS.87.13.5031
T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
P. Linsley (1990)
10.1146/ANNUREV.IY.08.040190.001511
Lymphokine control of in vivo immunoglobulin isotype selection.
F. Finkelman (1990)
10.1182/BLOOD.V75.7.1531.BLOODJOURNAL7571531
CD28 ligation in T-cell activation: evidence for two signal transduction pathways.
J. Ledbetter (1990)
10.1016/0167-5699(90)90085-N
Role of the CD28 receptor in T-cell activation.
C. June (1990)
10.1126/SCIENCE.1968289
Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells.
D. Woodland (1990)
10.1084/JEM.171.4.1315
Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells
J. Young (1990)
10.1016/0952-7915(91)90027-X
Roles of multiple accessory molecules in T-cell activation.
G. V. van Seventer (1991)
10.1084/JEM.173.3.721
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation
P. Linsley (1991)
10.1084/JEM.174.3.625
Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7
G. Freeman (1991)
10.1016/0092-8674(91)90462-8
CD8 is needed for development of cytotoxic T but not helper T cells
W. Fung-Leung (1991)
CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells.
M. Jenkins (1991)
10.1016/0008-8749(91)90091-O
Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway.
A. Freedman (1991)
10.1084/JEM.174.3.561
CTLA-4 is a second receptor for the B cell activation antigen B7
P. Linsley (1991)
10.1084/JEM.173.3.759
The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells
L. Koulova (1991)
10.1084/JEM.174.6.1425
Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression
W. Fung-Leung (1991)
10.1073/PNAS.88.15.6575
B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.
C. D. Gimmi (1991)
10.1093/INTIMM/3.3.229
IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T cell CD28: an amplification mechanism for T-B cell interactions.
A. Vallé (1991)
Signal transduction via CD4, CD8, and CD28 in mature and immature thymocytes. Implications for thymic selection.
L. A. Turka (1991)
10.1016/0167-5699(91)90066-3
Mls--a retrovirus exploits the immune system.
H. Acha-Orbea (1991)
10.1126/SCIENCE.1846244
Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28.
J. Fraser (1991)
Identification and distribution of the costimulatory receptor CD28 in the mouse.
J. Gross (1992)
Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7.
N. Damle (1992)
10.1016/0952-7915(92)90075-P
Costimulation of T-cell growth.
Y. Liu (1992)
10.1038/356607A0
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
F. Harding (1992)
10.1016/S0092-8674(05)80059-5
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
Lieping Chen (1992)
Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes.
N. Damle (1992)
10.1126/SCIENCE.1323143
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.
D. Lenschow (1992)
10.1016/S0092-8674(05)80055-8
Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
R. Schwartz (1992)
10.1002/EJI.1830221115
Co‐stimulation of murine CD4 T cell growth: cooperation between B7 and heat‐stable antigen
Y. Liu (1992)
10.1172/JCI115840
The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.
J. Young (1992)
Characterization of the Mlsf system. I. A novel "polymorphism" of endogenous superantigens.
R. Abe (1992)
10.1128/MCB.12.10.4357
Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28.
J. Fraser (1992)
10.1126/SCIENCE.1496399
Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule.
P. Linsley (1992)
Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation.
C. Cerdán (1992)
CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
G. Freeman (1992)
The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells.
S. D. Norton (1992)
10.1084/JEM.175.4.951
Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells
P. Vandenberghe (1992)
10.1073/PNAS.89.22.11102
T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.
L. A. Turka (1992)
CD28-induced T cell activation. Evidence for a protein-tyrosine kinase signal transduction pathway.
Y. Lu (1992)
10.1126/SCIENCE.7678351
Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.
S. E. Townsend (1993)
10.1084/JEM.177.1.165
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1
P. Tan (1993)



This paper is referenced by
10.21775/9781913652616.18
Immune Response to Borrelia: Lessons from Lyme Disease Spirochetes
L. Bockenstedt (2021)
10.1007/978-3-030-50826-5_9
Dynamic Regulation of T Cell Activation by Coupled Feedforward Loops
Gershom Buri (2021)
10.1038/s41598-021-94654-y
Virus Induced Lymphocytes (VIL) as a novel viral antigen-specific T cell therapy for COVID-19 and potential future pandemics
Rohan Sivapalan (2021)
10.1007/s12011-021-02900-1
Ellagic Acid from Terminalia arjuna Fruits Protects Against Chromium and Cobalt Toxicity in Primary Human Lymphocytes.
V. Bodiga (2021)
10.1038/s41467-021-24090-z
Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cells
Kosuke Miyauchi (2021)
10.1016/j.biomaterials.2021.120974
Convection enhanced delivery of light responsive antigen capturing oxygen generators for chemo-phototherapy triggered adaptive immunity.
Vishnu Sunil (2021)
10.1101/2021.05.07.442963
ARS2-directed alternative splicing mediates CD28 driven T cell glycolysis and effector function
G. Holling (2021)
10.1186/s12864-021-07435-2
Blinatumomab-induced T cell activation at single cell transcriptome resolution
Y. Huo (2021)
10.1038/s41418-020-00666-y
From the T-cell receptor to cancer therapy: an interview with Tak W. Mak
T. Mak (2020)
10.1128/mBio.01821-20
Phagosomal F-Actin Retention by Cryptococcus gattii Induces Dendritic Cell Immunoparalysis
K. Jamil (2020)
10.1186/s13075-020-2138-x
Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells
Po-Chun Liu (2020)
10.2174/1381612826666200130091318
Evolution of molecular targets in melanoma treatment.
Khanh B. Tran (2020)
10.1038/s41573-020-0081-9
Targeting co-stimulatory molecules in autoimmune disease
Natalie M. Edner (2020)
10.1111/all.14581
Vitamin A controls the allergic response through T follicular helper cell as well as plasmablast differentiation
Josephine Scholz (2020)
10.1080/2162402X.2020.1747349
Receptor signaling, transcriptional, and metabolic regulation of T cell exhaustion
M. Balkhi (2020)
10.3390/cancers12082117
Targeting Multiple Myeloma through the Biology of Long-Lived Plasma Cells
A. Utley (2020)
10.1073/pnas.1922600117
Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation
Norihisa Mikami (2020)
10.1016/j.celrep.2020.107815
CD28 Regulates Metabolic Fitness for Long-Lived Plasma Cell Survival
A. Utley (2020)
10.1016/j.scib.2020.08.007
A critical regulatory role for the cytoplasmic domain of CD28 in ligand binding in naive T cells
C. Qian (2020)
10.3390/toxins12040241
Talkin’ Toxins: From Coley’s to Modern Cancer Immunotherapy
Robert D Carlson (2020)
10.1101/2020.10.13.336537
The non-coding RNA miR-17~92 is a central mediator of T cell activation
Marianne Dölz (2020)
10.4049/jimmunol.2000347
A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells
Takaaki Oba (2020)
LYME DISEASE AND RELAPSING FEVER SPIROCHETES
L. Bockenstedt (2020)
10.1038/s41467-020-20070-x
B7-CD28 co-stimulation modulates central tolerance via thymic clonal deletion and Treg generation through distinct mechanisms
Masashi Watanabe (2020)
10.1101/2020.11.26.400390
A Novel Cell Therapy for COVID-19 and Potential Future Pandemics: Virus Induced Lymphocytes (VIL)
Rohan Sivapalan (2020)
10.1002/adbi.202000039
Artificial Biosystem for Modulation of Interactions between Antigen‐Presenting Cells and T Cells
Aseel Alatoom (2020)
10.1016/J.IOTECH.2020.09.001
Function and evolution of the prototypic CD28ζ and 4-1BBζ chimeric antigen receptors
J. Feucht (2020)
10.1007/s40472-019-00260-3
Belatacept and CD28 Costimulation Blockade: Preventing and Reducing Alloantibodies over the Long Term
R. Parsons (2019)
10.1007/978-981-32-9717-3_8
Stimulatory and Inhibitory Co-signals in Autoimmunity.
T. Okazaki (2019)
10.25911/5D7A261572F22
Characterising negative regulation of CD8+ T cell function in tolerance and exhaustion
M. Wagle (2019)
10.3389/fimmu.2019.00470
Regulation of Immune Function by the Lymphatic System in Lymphedema
R. Kataru (2019)
10.3389/fimmu.2019.00630
PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation
Reina Mizuno (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar